Gute Nachrichten! Tilray (TLRY) Receives First New Cannabis Cultivation License in Germany
    Gute Nachrichten! Tilray (TLRY) Receives First New Cannabis Cultivation License in Germany
    PRISM Cannabis

    July 22, 2024 - by Ashlee Vogenthaler

    Gute Nachrichten! Tilray (TLRY) Receives First New Cannabis Cultivation License in Germany

    22 July 2024

    New York, July 22, 2024 - PRISM MarketView - PRISM Cannabis Index company Tilray Brands, Inc. (TLRY), a global leader in cannabis research, cultivation, production, and distribution, announced today that its German cannabis cultivation facility, Aphria RX GmbH, has received the first new cannabis cultivation license issued under Germany’s new Cannabis Act, MedCanG. This license enables Aphria RX to cultivate and manufacture a wide range of medical cannabis, improving patient access to high-quality medical cannabis produced in Germany.
    To see this content properly accept cookies.
    Tilray, Inc. - Prism MarketView

    Tilray, Inc. - Prism MarketView

    Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products to patients, physicians, ph

    Read More

    In May 2019, Aphria RX was awarded the most comprehensive license for the cultivation of medical cannabis in Germany by the German Federal Institute for Drugs and Medical Devices (BfArM). This license included five lots totaling 1,000 kgs and uniquely allowed Aphria RX to grow all three strains of medical cannabis approved by BfArM.
    The introduction of the MedCanG Bill in Germany has significantly increased the number of patients and prescribers of medicinal cannabis. With the new license, Tilray is well-positioned to capitalize on this market opportunity. Aphria RX can now fully utilize its growing capacity and expand its genetics to 31 approved strains, up from the previously approved three strains.
    As a leader in medical cannabis research and production, Tilray believes these developments will positively impact patient health and well-being in Germany.
    About PRISM MarketView:
    To see this content properly accept cookies.
    Established in 2020, PRISM MarketView is dedicated to the monitoring and analysis of small cap stocks in burgeoning sectors. We deliver up-to-the-minute financial market news, provide comprehensive investor tools and foster a dynamic investor community. Central to our offerings are proprietary indexes that observe emerging sectors, including biotech, clean energy, next-generation tech, medical devices and beyond. Visit us at prismmarketview.com and follow us on Twitter.
    Disclaimer:
    PRISM MarketView is not a registered or licensed broker-dealer or investment adviser and does not offer investment advice. The information provided in this communication is not intended to constitute an offer to sell, a solicitation of an offer to buy, or a recommendation for any security.
    Contact:
    PRISM MarketView
    info@prismmarketview.com
    646-863-6341
    Prism MarketView | Stock Market News & Investment Opportunities
    To see this content properly accept cookies.
    We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
    Cookie settings
    Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
    Necessary cookies
    Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
    Preferences
    Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
    Analytical cookies
    Analytical cookies help us improve our website by collecting and reporting information on its usage.
    Marketing cookies
    Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.